Evidence map›Paper›PMID 36281348›Full record

ArticlePreventive medicine reports2022

Development and validation of the cervical cancer knowledge scale and HPV testing knowledge scale in a sample of Canadian women.

Ben Haward, Ovidiu Tatar, Patricia Zhu, Gabrielle Griffin-Mathieu, Samara Perez, Gilla K Shapiro, Emily McBride, Gregory D Zimet, Zeev Rosberger

Abstract read
In one paragraph

Article in Preventive medicine reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ben HawardLady Davis Institute for Medical Research (LDI), Jewish General Hospital, Montreal, QC, Canada.
Ovidiu TatarLady Davis Institute for Medical Research (LDI), Jewish General Hospital, Montreal, QC, Canada.
Patricia ZhuLady Davis Institute for Medical Research (LDI), Jewish General Hospital, Montreal, QC, Canada.
Gabrielle Griffin-MathieuLady Davis Institute for Medical Research (LDI), Jewish General Hospital, Montreal, QC, Canada.
Samara PerezLady Davis Institute for Medical Research (LDI), Jewish General Hospital, Montreal, QC, Canada.
Gilla K ShapiroDepartment of Supportive Care, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Emily McBrideDepartment of Behavioural Science and Health, University College London, London, UK.
Gregory D ZimetSchool of Medicine, Indiana University, IN, USA.
Zeev RosbergerLady Davis Institute for Medical Research (LDI), Jewish General Hospital, Montreal, QC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Knowledge of cervical cancer and HPV testing are important factors in proactive and continued engagement with screening and are critical considerations as countries move towards the implementation of HPV-based primary screening programs. However, existing scales measuring knowledge of both cervical cancer and HPV testing are not up to date with the current literature, lack advanced psychometric testing, or have suboptimal psychometric properties. Updated, validated scales are needed to ensure accurate measurement of these factors. Therefore, the aim of this study was to develop and validate two scales measuring cervical cancer knowledge and HPV testing knowledge. A pool of items was generated by retaining relevant existing items identified in a 2019 literature search and developing new items according to themes identified in recent systematic reviews. Items were assessed for relevance by the research team and then refined through seven cognitive interviews with Canadian women. A web-based survey including the remaining items (fourteen for each scale development) was administered to a sample of Canadian women in October and November of 2021. After data cleaning, N = 1027 responses were retained. Exploratory and Confirmatory Factor Analysis were conducted, and Item Response Theory was used to select items. The final cervical cancer knowledge scale (CCKS) and HPV testing knowledge scale (HTKS) were unidimensional, and each consisted of eight items. CFA demonstrated adequate model fit for both scales. The developed scales will be important tools to identify knowledge gaps and inform communications about cervical cancer screening, particularly in the context of HPV-based screening implementation.

Indexed as

CCKS, Cervical Cancer Knowledge ScaleCervical cancer knowledgeCervical cancer screeningCFA, Confirmatory Factor AnalysisEFA, Exploratory Factor AnalysisHPV, Human PapillomavirusHPV testingHPV testing knowledgeHTKS, HPV Testing Knowledge ScaleHuman PapillomavirusIRT, Item Response TheoryPsychosocial factorsScale development

Identifiers

PMID36281348
PMCPMC9587520

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.